Evidence map›Paper›PMID 24769368›Full record

ArticleDevelopmental biology2014

Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland.

Nadia Okolowsky, Priscilla A Furth, Paul A Hamel

Abstract read
In one paragraph

Article in Developmental biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Tamoxifen Resistance: Emerging Molecular Targets.International journal of molecular sciences · 2016
    Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Nadia OkolowskyDepartment of Laboratory Medicine & Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada M5S 1A8.
Priscilla A FurthLombardi Comprehensive Cancer Center, Departments of Oncology and Medicine, Georgetown University, Washington, DC, USA.
Paul A HamelDepartment of Laboratory Medicine & Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada M5S 1A8. Electronic address: paul.hamel@utoronto.ca.
University of Toronto · CAGeorgetown University · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Progression and regression of mammary preneoplasiaR01CA112176 · NCI · GEORGETOWN UNIVERSITY · PI FURTH, PRISCILLA A. · 2005 to 2018
$3.1M
CIHR MOP-97929NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA112176
6 · The paper itself

Abstract

Mesenchymal dysplasia (mes) mice harbour a truncation in the C-terminal region of the Hh-ligand receptor, Patched-1 (mPtch1). While the mes variant of mPtch1 binds to Hh-ligands with an affinity similar to that of wild type mPtch1 and appears to normally regulate canonical Hh-signalling via smoothened, the mes mutation causes, among other non-lethal defects, a block to mammary ductal elongation at puberty. We demonstrated previously Hh-signalling induces the activation of Erk1/2 and c-src independently of its control of smo activity. Furthermore, mammary epithelial cell-directed expression of an activated allele of c-src rescued the block to ductal elongation in mes mice, albeit with delayed kinetics. Given that this rescue was accompanied by an induction in estrogen receptor-alpha (ERα) expression and that complex regulatory interactions between ERα and c-src are required for normal mammary gland development, it was hypothesized that expression of ERα would also overcome the block to mammary ductal elongation at puberty in the mes mouse. We demonstrate here that conditional expression of ERα in luminal mammary epithelial cells on the mes background facilitates ductal morphogenesis with kinetics similar to that of the MMTV-c-src(Act) mice. We demonstrate further that Erk1/2 is activated in primary mammary epithelial cells by Shh-ligand and that this activation is blocked by the inhibitor of c-src, PP2, is partially blocked by the ERα inhibitor, ICI 182780 but is not blocked by the smo-inhibitor, SANT-1. These data reveal an apparent Hh-signalling cascade operating through c-src and ERα that is required for mammary gland morphogenesis at puberty.

Indexed as

MorphogenesisAnimalsCell LineEnzyme ActivationEpithelial CellsEstradiolEstrogen AntagonistsEstrogen Receptor alphaExtracellular Signal-Regulated MAP KinasesFemaleFibrocystic Breast DiseaseFulvestrantHedgehog ProteinsHEK293 CellsHumansMammary Glands, AnimalAG 1879EstradiolEstrogen AntagonistsEstrogen Receptor alphaExtracellular Signal-Regulated MAP KinasesFulvestrantHedgehog ProteinsPatched-1 ReceptorPatched ReceptorsPiperazinesProto-Oncogene Proteins pp60(c-src)PTCH1 protein, humanPtch1 protein, mousePyrazolesPyrimidinesReceptors, Cell SurfaceReceptors, G-Protein-CoupledSANT-1 compoundShh protein, mouseSmoothened ReceptorSmo protein, mouseEstrogen receptorHedgehog pathwayMammary glandMesenchymal dysplasiaPatched1

Identifiers

PMID24769368
PMCPMC4131199
OpenAlexW2091419984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.